Cargando…

New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells

Alport syndrome (AS) is an inherited genetic disorder characterized by range of alterations from glomerular basement membrane abnormalities up to end-stage renal disease. Pathogenic variants in the collagen α3, α4, and α5 encoding genes are causative both of the autosomal dominant and of the X-linke...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daga, Sergio, Donati, Francesco, Capitani, Katia, Croci, Susanna, Tita, Rossella, Giliberti, Annarita, Valentino, Floriana, Benetti, Elisa, Fallerini, Chiara, Niccheri, Francesca, Baldassarri, Margherita, Mencarelli, Maria Antonietta, Frullanti, Elisa, Furini, Simone, Conticello, Silvestro Giovanni, Renieri, Alessandra, Pinto, Anna Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080842/ https://www.ncbi.nlm.nih.gov/pubmed/31754267 http://dx.doi.org/10.1038/s41431-019-0537-8

Ejemplares similares

AAV-mediated FOXG1 gene editing in human Rett primary cells
por: Croci, Susanna, et al.
Publicado: (2020)

High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot
por: Croci, Susanna, et al.
Publicado: (2020)

Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome
por: Liu, Jian-Hong, et al.
Publicado: (2017)

Non-collagen genes role in digenic Alport syndrome
por: Daga, S., et al.
Publicado: (2019)

Identification of 27 Novel Variants in Genes COL4A3, COL4A4, and COL4A5 in Lithuanian Families With Alport Syndrome
por: Cerkauskaite, Agne, et al.
Publicado: (2022)

Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X‐linked Alport syndrome
por: Zhang, Yanqin, et al.
Publicado: (2019)

COL4A6 is dispensable for autosomal recessive Alport syndrome
por: Murata, Tomohiro, et al.
Publicado: (2016)

Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients
por: Mantovani, Stefania, et al.
Publicado: (2021)

Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women
por: Monticelli, Maria, et al.
Publicado: (2021)

Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique
por: Zhao, Xuechao, et al.
Publicado: (2019)

Genotype–phenotype correlations for COL4A3–COL4A5 variants resulting in Gly substitutions in Alport syndrome
por: Gibson, Joel T., et al.
Publicado: (2022)

RB1 Germline Variant Predisposing to a Rare Ovarian Germ Cell Tumor: A Case Report
por: Gelli, Elisa, et al.
Publicado: (2020)

Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research
por: Daga, Sergio, et al.
Publicado: (2021)

Exome Sequencing in 200 Intellectual Disability/Autistic Patients: New Candidates and Atypical Presentations
por: Valentino, Floriana, et al.
Publicado: (2021)

Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in COL4A6 and COL4A5
por: Zhou, Xi, et al.
Publicado: (2021)

Should We Diagnose Autosomal Dominant Alport Syndrome When There Is a Pathogenic Heterozygous COL4A3 or COL4A4 Variant?
por: Savige, Judy
Publicado: (2018)

Potentially Treatable Disorder Diagnosed Post Mortem by Exome Analysis in a Boy with Respiratory Distress
por: Imperatore, Valentina, et al.
Publicado: (2016)

Trimerization and Genotype–Phenotype Correlation of COL4A5 Mutants in Alport Syndrome
por: Kamura, Misato, et al.
Publicado: (2020)

Severe COVID-19 in Hospitalized Carriers of Single CFTR Pathogenic Variants
por: Baldassarri, Margherita, et al.
Publicado: (2021)

Novel heterozygous mutation in COL4A4 responsible for Alport syndrome in a Chinese family
por: Du, Ran, et al.
Publicado: (2022)

Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2022)

Creation of X-linked Alport syndrome rat model with Col4a5 deficiency
por: Namba, Masumi, et al.
Publicado: (2021)

The Contribution of COL4A5 Splicing Variants to the Pathogenesis of X-Linked Alport Syndrome
por: Yamamura, Tomohiko, et al.
Publicado: (2022)

Clinical and molecular characterization of COVID-19 hospitalized patients
por: Benetti, Elisa, et al.
Publicado: (2020)

Alport syndrome caused by a COL4A5 deletion and exonization of an adjacent AluY
por: Nozu, Kandai, et al.
Publicado: (2014)

Alport Syndrome: De Novo Mutation in the COL4A5 Gene Converting Glycine 1205 to Valine
por: Antón-Martín, Pilar, et al.
Publicado: (2012)

Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5
por: Yamamura, Tomohiko, et al.
Publicado: (2020)

The First COL4A5 Exon 41A Glycine Substitution in a Family With Alport Syndrome
por: Wang, Fang, et al.
Publicado: (2020)

Publisher Correction: Creation of X-linked Alport syndrome rat model with Col4a5 deficiency
por: Namba, Masumi, et al.
Publicado: (2021)

Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome
por: Liang, Lei, et al.
Publicado: (2023)

Heterozygous Pathogenic COL4A3 and COL4A4 Variants (Autosomal Dominant Alport Syndrome) Are Common, and Not Typically Associated With End-Stage Kidney Failure, Hearing Loss, or Ocular Abnormalities
por: Savige, Judy
Publicado: (2022)

PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis
por: Palmieri, Maria, et al.
Publicado: (2019)

SELP Asp603Asn and severe thrombosis in COVID-19 males
por: Fallerini, Chiara, et al.
Publicado: (2021)

Correction: SELP Asp603Asn and severe thrombosis in COVID-19 males
por: Fallerini, Chiara, et al.
Publicado: (2023)

Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus
por: Štabuc-Šilih, Mirna, et al.
Publicado: (2009)

Omic Approach in Non-smoker Female with Lung Squamous Cell Carcinoma Pinpoints to Germline Susceptibility and Personalized Medicine
por: Baldassarri, Margherita, et al.
Publicado: (2018)

A family case of X-linked Alport syndrome patients with a novel variant in COL4A5
por: Kashiwagi, Yasuyo, et al.
Publicado: (2018)

Low frequency of parental mosaicism in de novo COL4A5 mutations in X‐linked Alport syndrome
por: Helle, Ole Magnus Bjorgaas, et al.
Publicado: (2020)

Compound Mutations of the COL4A3 including a Novel Allele Identified in a Patient with Alport Syndrome
por: Wang, Zhendong, et al.
Publicado: (2020)

A glycine substitution in the collagenous domain of Col4a3 in mice recapitulates late onset Alport syndrome
por: Odiatis, Christoforos, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e25ops93qc05s5r05d2bkdnmso